Vous êtes ici :
Click here to see the meta data of this asset.


Reconsidering Medication Discontinuation After a First Episode of Psychosis

Dr. Robert Zipursky presents Grand Rounds at CAMH in April 2018

Learning objectives: Outline the different study methodologies used to determine recurrence rates following a first episode of psychosis, as well as their limitations; Describe the risk of recurrence with and without maintenance medications for individuals who have remitted from a first episode of psychosis; Describe the risk of developing schizophrenia and bipolar disorder when a person has a first episode of cannabis-induced psychosis. 


Personalized medicine: Pharmacogenetics

These videos offer an introduction to pharmacogenetics in mental health and addiction and explore some of the legal considerations of using genetic information.  

Dr. James Kennedy, Head of Neuroscience Research at the Centre for Addiction and Mental Health (CAMH), teaches a continuing education course on pharmacogenetics and explains the basic ideas and practices, and Candi Gogar, research legal counsel at CAMH, explains the legal considerations.



Vous n'avez pas le rôle requis pour accéder à cette application (portlet).